EPO Patents = 1

Forward Citations = 35

Loading Chart...

2 inventors (with patents filed for the assignee):

Alex Nivorozhkin (7 out of 32 patents)

Nelson Landrau (7 out of 21 patents)

7 patents: Sort by Forward Citations

1. 11613515 - Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods (2023-03-28),

2. 11603348 - Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods (2023-03-14),

3. 11554100 - Single-layer oral dose of neuro-attenuating ketamine (2023-01-17),

4. 10981859 - Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods (2021-04-20),

5. 10653629 - Single layer oral dose of neuro-attenuating ketamine (2020-05-19),

6. 10252982 - Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods (2019-04-09),

7. 9913803 - Single-layer oral dose of neuro-attenuating ketamine (2018-03-13),

Company Overview

Amorsa Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for neurological disorders. Our mission is to harness the power of neuroplasticity to create novel treatments that improve the lives of patients. With a strong pipeline of drug candidates targeting various neurological conditions, we are committed to advancing the field of neurology and bringing hope to those in need.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#7 in Littleton, MA

#2,306 in Massachusetts

#39,929 in US

Littleton, MA, United States of America

Amorsa Therapeutics, Inc.

Forward Citations = 35

2 inventors:

Alex Nivorozhkin (7 out of 32 patents)

Nelson Landrau (7 out of 21 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Amorsa Therapeutics, Inc.. Retrieved from https://idiyas.com/company/amorsa-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]